Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery.
Harman S ParharKendall TascheRobert M BrodyGregory S WeinsteinBert W O'MalleyRabie M ShantiJason G NewmanPublished in: Head & neck (2020)
While specific evidence regarding SARS-CoV-2 is lacking, PVP-I-based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS-CoV-2 aerosolization during upper airway mucosal surgery.